California Stem Cell Agency Pumped Nearly $1 Billion into Neuro Disease Research

Its first-ever portfolio report breaks down the details, sets the stage for examination of spending priorities

This CIRM chart deals only with clinical-stage research funding. More spending charts can be found here.

During the last 16 years, California’s stem cell agency poured $975 million into its search for cures and treatments for neuro diseases ranging from brain cancer to epilepsy, according to figures made public for the first time yesterday. 

The expendit…